American Assets Inc. Acquires New Holdings in Kenvue Inc. $KVUE

American Assets Inc. bought a new stake in Kenvue Inc. (NYSE:KVUE) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 35,000 shares of the company’s stock, valued at approximately $568,000. Kenvue comprises about 0.2% of American Assets Inc.’s investment portfolio, making the stock its 22nd largest holding.

Other large investors have also added to or reduced their stakes in the company. Salomon & Ludwin LLC bought a new position in shares of Kenvue during the 3rd quarter worth approximately $25,000. NBT Bank N A NY grew its holdings in Kenvue by 180.3% in the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the last quarter. Cornerstone Planning Group LLC grew its holdings in Kenvue by 705.2% in the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after purchasing an additional 1,361 shares during the last quarter. Golden State Wealth Management LLC increased its position in shares of Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont lifted its holdings in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after purchasing an additional 804 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on KVUE. Deutsche Bank Aktiengesellschaft set a $18.00 target price on Kenvue in a research note on Friday, October 24th. Edward Jones lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Johnson Rice restated a “neutral” rating on shares of Kenvue in a report on Tuesday, October 28th. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Four analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $19.46.

Kenvue Stock Up 0.3%

Shares of KVUE stock opened at $18.12 on Friday. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The firm has a market capitalization of $34.72 billion, a PE ratio of 24.16 and a beta of 0.59. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 0.98. The stock’s 50-day simple moving average is $17.24 and its 200-day simple moving average is $17.87.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.6%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction that occurred on Friday, December 12th. The stock was bought at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares of the company’s stock, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.68% of the stock is currently owned by company insiders.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.